基本信息
浏览量:0
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
个人简介
Dr. T. Shantha Raju (Raju) is a biotech executive and has more than 25 years of biotech industry experience. He is currently working as an executive for a stealth mode biotech company. Prior to this he worked at CHO Plus, Venn Therapeutics and also as a Senior Director at Medimmune. Prior to Medimmune Dr. Raju was a Scientific Director at Janssen R&D of Janssen Pharmaceutical Companies of JNJ. Dr. Raju joined Centocor Inc in 2004 which became Janssen R&D in 2011. At Centocor Dr. Raju has worked as an Assistant Director and then as a Research Fellow. Prior to Centocor, Dr. Raju has spent more than 5 years at Genentech and little more than a year at Fibrogen. Dr. Raju’s research interest is to explore structure-function relationship of antibody glycosylation and glycoprotein therapeutics. Dr. Raju has more than 18 years of experience in the research and development of biotherapeutics including monoclonal antibodies and glycoproteins. Dr. Raju was involved in the development of leading cancer therapeutics such as Rituxan, Herceptin, Avastin and immunology therapeutics such as Remicade, Simponi etc. Dr. Raju has published more than 40 research articles, several reviews and book chapters. He is currently in the editorial board of mAbs, Analytical Biochemistry, BioProcess International and Drug Discovery and Development journals. Dr. Raju has been a member of ACS and Division of Carbohydrate for the last 25 years. He is also a member of ASBMB for the past 18 years.
研究兴趣
论文共 53 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
CO- AND POST-TRANSLATIONAL MODIFICATIONS OF THERAPEUTIC ANTIBODIES AND PROTEINSpp.163-175, (2019)
引用22浏览0引用
22
0
CO- AND POST-TRANSLATIONAL MODIFICATIONS OF THERAPEUTIC ANTIBODIES AND PROTEINSpp.XV-+, (2019)
CO- AND POST-TRANSLATIONAL MODIFICATIONS OF THERAPEUTIC ANTIBODIES AND PROTEINSpp.183-202, (2019)
引用3浏览0引用
3
0
CO- AND POST-TRANSLATIONAL MODIFICATIONS OF THERAPEUTIC ANTIBODIES AND PROTEINS (2019)
引用0浏览0引用
0
0
CO- AND POST-TRANSLATIONAL MODIFICATIONS OF THERAPEUTIC ANTIBODIES AND PROTEINSpp.239-252, (2019)
引用0浏览0引用
0
0
CO- AND POST-TRANSLATIONAL MODIFICATIONS OF THERAPEUTIC ANTIBODIES AND PROTEINSpp.133-146, (2019)
引用3浏览0引用
3
0
CO- AND POST-TRANSLATIONAL MODIFICATIONS OF THERAPEUTIC ANTIBODIES AND PROTEINSpp.207-210, (2019)
引用1浏览0引用
1
0
CO- AND POST-TRANSLATIONAL MODIFICATIONS OF THERAPEUTIC ANTIBODIES AND PROTEINSpp.203-206, (2019)
引用0浏览0引用
0
0
CO- AND POST-TRANSLATIONAL MODIFICATIONS OF THERAPEUTIC ANTIBODIES AND PROTEINS (2019)
引用3浏览0引用
3
0
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn